G581-0373 Screening compound: 4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide

G581-0373 Screening compound: 4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide
G581-0373 Screening compound: 4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G581-0373
4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G581-0373

Molecular Formula

C27H29N5O2 (C27 H29 N5 O2)

Compound Name

4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide

IUPAC name

4-[2-(1-methyl-1H-indol-3-yl)-5-oxo-4H5H6H7H-pyrazolo[15-a]pyrimidin-4-yl]-N-(1-phenylethyl)butanamide

SMILES

CC(c1ccccc1)NC(CCCN(c1cc(-c2cn(C)c3c2cccc3)nn1CC1)C1=O)=O

InChI

InChI=1S/C27H29N5O2/c1-19(20-9-4-3-5-10-20)28-25(33)13-8-15-31-26-17-23(29-32(26)16-14-27(31)34)22-18-30(2)24-12-7-6-11-21(22)24/h3-7,9-12,17-19H,8,13-16H2,1-2H3,(H,28,33)/t19-/m0/s1

InChI Key

PXSMXHZNAMPTIJ-IBGZPJMESA-N

MDL Number (MFCD)

MFCD15020622

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.139

Distribution Coefficient, logD

3.139

Water Solubility, LogSw

-3.34

Polar Surface Area

54.193

Acid Dissociation Constant (pKa)

12.99

Base Dissociation Constant (pKb)

2.11

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.60

G581-0373 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with G581-0373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G581-0373?
Check Price and Availability of G581-0373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G581-0373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G581-0373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G581-0373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G581-0373 available by request